Brief: Wpd And Cns Pharmaceuticals Announce Positive Opinion Of Polish Central Ethics Committee For Wpd-201 Study And Central Irb Study Level Approval For Cns-201 Study
Feb 18 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* WPD AND CNS PHARMACEUTICALS ANNOUNCE POSITIVE OPINION OF
POLISH
CENTRAL ETHICS COMMITTEE FOR WPD-201 STUDY AND CENTRAL IRB STUDY
LEVEL APPROVAL FOR CNS-201 STUDY
Source text for Eikon: ID:nPn5Mqmm1a
Further company coverage: CNSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026